SpringWorks Therapeutics ...

NASDAQ: SWTX · Real-Time Price · USD
46.99
0.00 (0.00%)
At close: Jun 30, 2025, 3:59 PM

SpringWorks Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-258.13M -325.1M -277.42M -173.91M
Depreciation & Amortization
3.47M 1.67M 765K 490K
Stock-Based Compensation
109.14M 94.53M 72.97M 38.44M
Other Working Capital
4.95M 8.65M 33.94M 3.04M
Other Non-Cash Items
7.79M 6.69M 4.02M 993K
Deferred Income Tax
n/a n/a n/a 988K
Change in Working Capital
-37.86M -583K 38.1M 5.12M
Operating Cash Flow
-175.6M -222.79M -161.56M -127.88M
Capital Expenditures
-4.45M -7.38M -10.2M -2.02M
Cash Acquisitions
n/a -2.8M -4.2M 2.02M
Purchase of Investments
-285.1M -575.72M -481.05M -305.42M
Sales Maturities Of Investments
378.58M 620.66M 279.85M 391.03M
Other Investing Acitivies
-24.48M n/a -205.4M -2.02M
Investing Cash Flow
64.55M 34.75M -215.6M 83.59M
Debt Repayment
n/a n/a n/a n/a
Common Stock Repurchased
-8.44M -2.8M -1.34M n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
4.76M 139K 1.98M 1.16M
Financial Cash Flow
4.76M 296.64M 340.7M 1.16M
Net Cash Flow
-106.29M 108.6M -36.46M -43.13M
Free Cash Flow
-180.05M -230.18M -171.76M -129.89M